|Day Low/High||16.14 / 16.32|
|52 Wk Low/High||11.25 / 22.66|
It's apparently not all doom and gloom in the private-equity realm of stock picking these days.
Clearlake Capital Group, L.P.
Private equity firms are cutting their stakes in some companies amid perceived overvaluations in the market.
Names that shareholders should watch are those where PE firms hold big stakes in their companies.
Stocks with insider trader activity include FII, HABT and CG
Carlyle (CG) could make two acquisitions in Japan worth $2 billion each.
Server and storage provider faces cloud competition, but may be takeover bait.
Adopt the private equity mindset by investing in CG when it is cheap.
The firm's latest earnings report is chock full of good advice.
Don't buy the shares, invest in puts and other instruments instead.
A source familiar with the matter said that TSG Consumer Partners earned 25 times its 2013 minority investment in the makeup company.
Biogen's announcement that CEO George Scangos would step down as head of the biotech company marks the latest company to see its chief leave the perch this year.
These firms' execs used the post-Brexit meltdown to buy more shares.
These 3 dividend stocks are rated a Sell by TheStreet
The Permian Basin player could be the first oil and gas exploration and production company to debut on the public markets in more than a year.
The buyer, Symantec, sees about $150 million in cost savings from the transaction.
The easiest solution for private equity firms evaluating the impact of rising rates on the companies they own is to replace some of those companies' debt with equity.
The markets took Friday's weak employment number pretty well, so Cramer's game plan focuses on a weaker U.S. dollar.
Large publicly-traded private equity firms have seen their share prices drop significantly over the past year but they are virtually impenetrable when it comes to shareholder insurgencies. Here's why.
Cramer says VF is doing a terrific job but he's avoiding China Mobile.
The health care giant's $3 billion purchase of the Carlyle-backed shampoo group will take its U.S. market share from No. 8 to No. 4.
The OGX shampoo maker's selling shareholders are founder Todd Christopher and Carlyle.